subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038

object_name: esophageal cancer

tested_intervention: unsure


subject: CHEBI:2038

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:2038

object_name: neoplasm of esophagus


subject: CHEBI:2038

object_name: gastroesophageal cancer


subject: CHEBI:47898

subject_name: Epirubicin


subject: UMLS:C5782768

subject_name: BUPivacaine 0.25% injectable solution

object_name: Labor Pain


subject: UMLS:C5782788

subject_name: ROPivacaine 0.1% injectable solution


subject: UMLS:C5853669

object_name: radiodermatitis

tested_intervention: yes


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: Thrombasthenia


subject: UMLS:C0593103

subject_name: Novoseven


subject: PR:000007301

subject_name: coagulation factor VII


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C1134664

object_name: prostate carcinoma


subject: UMLS:C1134664

object_name: prostate cancer


subject: UNII:1C25MR0H0E

object_name: Diabetic Neuralgia


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: pancreatic neoplasm


subject: UMLS:C1172402

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1172402

object_name: malignant pancreatic neoplasm


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C5667030

subject_name: Icovamenib

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5667030

object_name: plasma cell myeloma


subject: UMLS:C5667030

object_name: adult lymphoma


subject: UMLS:C5667030

object_name: lymphoma


subject: UMLS:C5667030

object_name: pediatric lymphoma


subject: UMLS:C5667030

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5667030

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5667030

object_name: acute myeloid leukemia


subject: UMLS:C5667030

object_name: acute lymphoblastic leukemia


subject: UMLS:C5667030

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5667030

object_name: non-Hodgkin lymphoma


subject: UMLS:C5667030

object_name: acute biphenotypic leukemia


subject: UMLS:C5667030

object_name: mixed phenotype acute leukemia


subject: UMLS:C5667030

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C5667030

object_name: Disease Progression


subject: UMLS:C5667030

object_name: cancer


subject: UMLS:C5667030

object_name: neoplasm


subject: CHEBI:176724

subject_name: Etiracetam

object_name: fibromyalgia


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UMLS:C4550125

object_name: wet macular degeneration


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: pervasive developmental disorder


subject: UMLS:C3714803

object_name: autism


subject: UMLS:C3714803

object_name: autism spectrum disorder


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:7772

subject_name: omeprazole

object_name: colorectal cancer


subject: CHEBI:7772

object_name: colorectal carcinoma


subject: CHEBI:7772

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Graft Rejection


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:33375

subject_name: Gadolinium

object_name: chronic kidney disease


subject: CHEBI:33375

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:33375

object_name: Myocardial fibrosis


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: PUBCHEM.COMPOUND:76641559

subject_name: Dorzagliatin

object_name: type 2 diabetes mellitus


subject: CHEBI:151315

subject_name: Heparin

object_name: Insulin resistance


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374

object_name: obesity due to melanocortin 4 receptor deficiency


subject: KEGG.COMPOUND:C00374

object_name: obesity


subject: KEGG.COMPOUND:C00374

object_name: Obesity, CTCAE


subject: UMLS:C4087030

object_name: Rett syndrome


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Postoperative Pain, Chronic


subject: CHEBI:28939

object_name: osteoarthritis, knee


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: cellulitis


subject: CHEBI:41879

object_name: cellulitis on exam (physical finding)


subject: CHEBI:33349

subject_name: dubnium atom

object_name: multiple sclerosis


subject: PR:000001875

subject_name: leptin receptor


subject: UMLS:C0719794

subject_name: Desmopressin Acetate Nasal

object_name: no feeling or sensation of skin


subject: UMLS:C0719794

object_name: Sensory Loss


subject: CHEBI:60791

subject_name: Xylocard

object_name: hypertension


subject: CHEBI:60791

object_name: Hypertension, CTCAE


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:10033

subject_name: Warfarin

object_name: metachromatic leukodystrophy


subject: CHEBI:10033

object_name: metachromatic leukodystrophy, juvenile form


subject: CHEBI:92223

subject_name: Abexinostat

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:92223

object_name: cancer


subject: CHEBI:92223

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: CHEMBL.COMPOUND:CHEMBL4298036

subject_name: CURCUMINOIDS

object_name: thalassemia


subject: UMLS:C4086228

subject_name: Curcuminoid


subject: PUBCHEM.COMPOUND:425400

subject_name: alpha-Tocopherol succinate


subject: CHEBI:230570


subject: CHEBI:22470

subject_name: alpha-tocopherol


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:28939


subject: CHEBI:68554

subject_name: Deferiprone


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: mumps


subject: UNII:9J2M48GC2M

subject_name: SAFUSIDENIB ERBUMINE

object_name: glioma


subject: UNII:9J2M48GC2M

object_name: malignant glioma


subject: DRUGBANK:DB17523

object_name: lung cancer


subject: DRUGBANK:DB17523

object_name: lung neoplasm


subject: DRUGBANK:DB17523

object_name: lung carcinoma


subject: DRUGBANK:DB17523

object_name: Neck Carcinoma


subject: DRUGBANK:DB17523

object_name: head and neck neoplasm


subject: DRUGBANK:DB17523

object_name: head and neck cancer


subject: DRUGBANK:DB17523

object_name: uterine cancer


subject: DRUGBANK:DB17523

object_name: tumor of uterus


subject: DRUGBANK:DB17523

object_name: renal carcinoma


subject: DRUGBANK:DB17523

object_name: kidney cancer


subject: DRUGBANK:DB17523

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB17523

object_name: breast carcinoma


subject: DRUGBANK:DB17523

object_name: breast cancer


subject: DRUGBANK:DB17523

object_name: bladder tumor


subject: DRUGBANK:DB17523

object_name: urinary bladder carcinoma


subject: DRUGBANK:DB17523

object_name: urinary bladder cancer


subject: DRUGBANK:DB17523

object_name: childhood bladder carcinoma


subject: DRUGBANK:DB17523

object_name: ovarian cancer


subject: DRUGBANK:DB17523

object_name: ovarian neoplasm


subject: DRUGBANK:DB17523

object_name: ovarian carcinoma


subject: DRUGBANK:DB17523

object_name: prostate carcinoma


subject: DRUGBANK:DB17523

object_name: prostate cancer


subject: DRUGBANK:DB17523

object_name: carcinoma of urethra


subject: DRUGBANK:DB17523

object_name: urethra cancer


subject: DRUGBANK:DB17523

object_name: melanoma


subject: PUBCHEM.COMPOUND:3367

object_name: Chronic myeloid leukemia in remission


subject: PUBCHEM.COMPOUND:3367

object_name: myeloproliferative syndrome


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W

object_name: Acute lymphoid leukemia in remission


subject: UNII:D7RD81HE4W

object_name: Acute myeloid leukemia in remission


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W

object_name: bone marrow neoplasm


subject: UNII:D7RD81HE4W

object_name: Adult Hodgkin Lymphoma


subject: UNII:D7RD81HE4W

object_name: Childhood Hodgkin Lymphoma


subject: UNII:D7RD81HE4W

object_name: plasma cell myeloma


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Indolent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: lymphoplasmacytic lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: lymphoproliferative syndrome


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Merkel cell polyomavirus infection


subject: UMLS:C3896806


subject: UMLS:C0751599

subject_name: Betantrone


subject: PR:000015526

subject_name: transcription factor Spi-C

object_name: Tooth extraction status NOS


subject: PR:000015526

object_name: Tooth Fractures


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: UMLS:C0033374


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:70789204

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:70789204

object_name: coronary restenosis


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: plantar fasciitis


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Atopic rhinitis


subject: PUBCHEM.COMPOUND:54675783

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C4733686

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4733686

object_name: fallopian tube carcinoma


subject: UMLS:C4733686

object_name: fallopian tube cancer


subject: UMLS:C4733686

object_name: primary peritoneal carcinoma


subject: UMLS:C4733686

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C4733686

object_name: peritoneal carcinoma


subject: PUBCHEM.COMPOUND:135618605

subject_name: poly If

object_name: Overweight and obesity


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7


subject: UNII:DOB7Y3RSX0

object_name: Non-small cell lung cancer stage 0


subject: UNII:DOB7Y3RSX0

object_name: Non-small cell lung cancer recurrent


subject: UNII:DOB7Y3RSX0

object_name: lung large cell carcinoma


subject: UNII:DOB7Y3RSX0

object_name: squamous cell lung carcinoma


subject: UNII:DOB7Y3RSX0

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:2877953

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:2877953

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:2877953

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:2877953

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C2699571

subject_name: sotatercept


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: CHEBI:7936

subject_name: Paroxetine

object_name: generalized anxiety disorder


subject: CHEBI:36796

subject_name: duloxetine

object_name: social phobia


subject: CHEBI:36796

object_name: panic disorder


subject: CHEBI:36796

object_name: panic disorder 1


subject: CHEBI:36796

object_name: Compulsion


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:45652

subject_name: Succinylcholine

object_name: Postoperative Complications


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: scleroderma


subject: CHEBI:39548

object_name: systemic sclerosis


subject: UNII:4UN9AOU6G8

object_name: kidney failure


subject: UNII:4UN9AOU6G8

object_name: chronic kidney disease


subject: UNII:4UN9AOU6G8

object_name: Chronic uremia


subject: UMLS:C0114857

subject_name: Dotarem

object_name: CNS disorder


subject: CHEBI:73727


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: chordoma


subject: CHEBI:132967

subject_name: Elbasvir

object_name: HIV Coinfection


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: pneumonia


subject: KEGG.COMPOUND:C00374

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: endogenous depression


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins

object_name: malignant tumor of nasopharynx


subject: PUBCHEM.COMPOUND:187888

object_name: Metastatic malignant neoplasm to liver


subject: CHEMBL.COMPOUND:CHEMBL4297747

subject_name: ENDOSTATIN


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: UMLS:C0534628


subject: UMLS:C1705207

subject_name: Endostar


subject: CHEBI:140478

subject_name: Pavinetant

object_name: Androgen excess


subject: CHEBI:180905

subject_name: Nicardipine

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: biliary tract cancer


subject: GTOPDB:11376

object_name: cholangiocarcinoma


subject: GTOPDB:11376

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEBI:94534

subject_name: olanzapine

object_name: HIV infection


subject: UMLS:C3827162

object_name: cancer


subject: UMLS:C3827162

object_name: neoplasm


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: resistant hypertension


subject: UMLS:C4033631

object_name: Hypertension resistant to conventional therapy


subject: UMLS:C4033631

object_name: Blood Pressure Finding


subject: UMLS:C4033631

object_name: Systemic arterial pressure


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Perimenopausal disorder


subject: CHEBI:144903

object_name: Abnormal menstrual cycle


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PUBCHEM.COMPOUND:14581826

subject_name: Naltrexol

object_name: opiate dependence


subject: CHEBI:192658


subject: CHEBI:32682

subject_name: L-argininium

object_name: schizophrenia 18


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UNII:97B5KCW80W

subject_name: Bimosiamose

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:46874763

object_name: Anal abscess


subject: PUBCHEM.COMPOUND:46874763

object_name: anal fistula


subject: PUBCHEM.COMPOUND:46874763

object_name: Anal Fistula, CTCAE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3871468

subject_name: ciprofloxacin and metronidazole


subject: UMLS:C3871468


subject: UMLS:C3871468


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:167450

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:167450

object_name: chronic leukemia


subject: CHEBI:167450

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:123315041

subject_name: VIBEGRON

object_name: Vasodilation disorder


subject: PUBCHEM.COMPOUND:123315041

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:123315041

object_name: Menopause


subject: PUBCHEM.COMPOUND:123315041

object_name: Hypoxemia


subject: PUBCHEM.COMPOUND:123315041

object_name: Hypoxia, CTCAE


subject: CHEBI:27732

subject_name: Caffeine

object_name: Postoperative delirium


subject: CHEBI:27732

object_name: Emergence Delirium


subject: CHEBI:27732

object_name: Postoperative cognitive dysfunction


subject: CHEBI:27732

object_name: mild neurocognitive disorder


subject: CHEBI:27732

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:9829502

subject_name: Emricasan


subject: GTOPDB:4897

subject_name: ciliary neurotrophic factor

object_name: macular telangiectasia type 2


subject: CHEMBL.COMPOUND:CHEMBL4298063

subject_name: CILIARY NEUROTROPHIC FACTOR


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: Cognitive impairment


subject: CHEBI:41423

subject_name: Celecoxib

object_name: mood disorder


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Local anaesthetics causing adverse effects in therapeutic use


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:4907

subject_name: Etidronic acid

object_name: Fahr's disease


subject: CHEBI:4907

object_name: basal ganglia calcification, idiopathic, 1


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: Metastatic Breast Lobular Carcinoma


subject: CHEBI:134703

object_name: invasive lobular breast carcinoma


subject: CHEBI:134703

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:134703

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL5095039

subject_name: GALLIUM GA 68 GOZETOTIDE


subject: CHEMBL.COMPOUND:CHEMBL5095039


subject: CHEMBL.COMPOUND:CHEMBL5095039


subject: CHEMBL.COMPOUND:CHEMBL5095039


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic cholangiocarcinoma


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: Cholangiocarcinoma non-resectable


subject: PUBCHEM.COMPOUND:51038893

object_name: gallbladder carcinoma


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: rotator cuff syndrome


subject: CHEBI:89324

object_name: Rotator cuff tear


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Inflammation


subject: UNII:R8DG7T2D3A

object_name: Increased reactive oxygen species production


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: immune system disorder


subject: UNII:3A189DH42V

object_name: T cell immunodeficiency primary


subject: UNII:3A189DH42V

object_name: common variable immunodeficiency


subject: UNII:3A189DH42V

object_name: Acquired Hypogammaglobulinemia


subject: UNII:3A189DH42V

object_name: lymphoproliferative syndrome


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C0699319

subject_name: Cytoxan


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: UMLS:C0699319


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:90881

subject_name: Camptosar

object_name: Refractory Ewing Sarcoma


subject: CHEBI:90881

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:90881

object_name: Refractory Childhood Malignant Germ Cell Tumor


subject: CHEBI:90881

object_name: Refractory Malignant Germ Cell Tumor


subject: CHEBI:90881

object_name: Recurrent Malignant Germ Cell Tumor


subject: CHEBI:90881

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:90881

object_name: Recurrent Rhabdoid Tumor


subject: CHEBI:90881

object_name: Refractory Osteosarcoma


subject: CHEBI:90881

object_name: Refractory Soft Tissue Sarcoma


subject: CHEBI:90881

object_name: Refractory Rhabdoid Tumor


subject: CHEBI:90881

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:90881

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:90881

object_name: Recurrent Soft Tissue Sarcoma


subject: CHEBI:90881

object_name: Refractory Hepatoblastoma


subject: CHEBI:90881

object_name: Hepatoblastoma recurrent


subject: CHEBI:90881

object_name: Recurrent Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313

object_name: Ewing's sarcoma recurrent


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Refractory Malignant Solid Neoplasm


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Osteosarcoma recurrent


subject: GTOPDB:8313

object_name: Refractory Neuroblastoma


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: GTOPDB:8313

object_name: Recurrent Rhabdomyosarcoma


subject: GTOPDB:8313

object_name: Refractory Rhabdomyosarcoma


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Neuroblastoma recurrent


subject: GTOPDB:8313


subject: GTOPDB:8313

object_name: Refractory Peripheral Primitive Neuroectodermal Tumor


subject: GTOPDB:8313


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Refractory Ewing Sarcoma


subject: UMLS:C0919079


subject: UMLS:C0919079

object_name: Recurrent Kidney Wilms Tumor


subject: UMLS:C0919079

object_name: Refractory Childhood Malignant Germ Cell Tumor


subject: UMLS:C0919079

object_name: Refractory Malignant Germ Cell Tumor


subject: UMLS:C0919079

object_name: Recurrent Malignant Germ Cell Tumor


subject: UMLS:C0919079

object_name: Recurrent Rhabdoid Tumor


subject: UMLS:C0919079

object_name: Refractory Soft Tissue Sarcoma


subject: UMLS:C0919079

object_name: Refractory Rhabdoid Tumor


subject: UMLS:C0919079

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C0919079

object_name: Recurrent Soft Tissue Sarcoma


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079

object_name: Refractory Hepatoblastoma


subject: UMLS:C0919079

object_name: Hepatoblastoma recurrent


subject: UMLS:C0919079

object_name: Recurrent Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564

object_name: Ewing's sarcoma recurrent


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:72564

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UNII:306QR91I9R

subject_name: Pelabresib


subject: UNII:306QR91I9R

object_name: neoplasm


subject: UNII:306QR91I9R

object_name: leukemia


subject: UNII:306QR91I9R

object_name: childhood leukemia


subject: UNII:306QR91I9R

object_name: essential thrombocythemia


subject: UNII:306QR91I9R

object_name: hematologic disorder


subject: UNII:306QR91I9R

object_name: acute myeloid leukemia


subject: UNII:306QR91I9R

object_name: myeloproliferative neoplasm


subject: UNII:306QR91I9R

object_name: Myelodysplasia


subject: UNII:306QR91I9R

object_name: Neoplasms by Histologic Type


subject: UNII:306QR91I9R

object_name: precancerous condition


subject: UNII:306QR91I9R

object_name: bone marrow disorder


subject: CHEBI:189653

subject_name: pelabresib


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: CHEBI:189653


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: UMLS:C5707688


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:91327

subject_name: Tivozanib

object_name: prostate carcinoma


subject: CHEBI:91327

object_name: prostate cancer


subject: CHEBI:3423

subject_name: Carmustine

object_name: graft versus host disease


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: DS Stage I Plasma Cell Myeloma


subject: MESH:D002136

object_name: ISS Stage I Plasma Cell Myeloma


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C4724142

subject_name: Amorphous Calcium Carbonate

object_name: hypoparathyroidism


subject: UMLS:C4724142

object_name: Hypoparathyroidism, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4650442

object_name: Guillain-Barre Syndrome, CTCAE


subject: UMLS:C5705578


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: fibromyalgia


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: GTOPDB:11762

subject_name: livmoniplimab

object_name: non-small cell lung carcinoma


subject: UNII:42SH7JCD82

subject_name: LIVMONIPLIMAB


subject: UMLS:C5237368

subject_name: ARGX 115


subject: UMLS:C5772966

object_name: pelvic inflammatory disease


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: Auditory hallucination


subject: CHEBI:8874

object_name: psychosis


subject: CHEBI:8874

object_name: Nonorganic psychosis


subject: CHEBI:8874

object_name: Psychosis, CTCAE


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: nasopharyngeal carcinoma


subject: CHEBI:194095

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:49668

subject_name: Gefitinib

object_name: acute myeloid leukemia


subject: UMLS:C5960795

object_name: Childhood Solid Neoplasm


subject: UMLS:C5960795

object_name: Adult Solid Neoplasm


subject: UMLS:C5960795

object_name: Solid Neoplasm


subject: UNII:V6SX910Y31

subject_name: VEVORISERTIB


subject: UNII:V6SX910Y31

object_name: cancer


subject: UNII:V6SX910Y31

object_name: neoplasm


subject: UMLS:C5448042

subject_name: Vevorisertib


subject: UMLS:C5448042


subject: UMLS:C5448042


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: Breast cancer stage II


subject: UMLS:C1882421

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C1882421

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: malignant neoplasm of breast stage I


subject: UMLS:C1882421

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: Carcinoma breast stage I


subject: UMLS:C1882421

object_name: estrogen receptor-negative breast cancer


subject: UMLS:C1882421

object_name: progesterone receptor-negative breast cancer


subject: UMLS:C1882421

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1882421

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1882421

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Right ventricular failure


subject: CHEBI:231425

object_name: tricuspid valve insufficiency


subject: CHEBI:9637

subject_name: Torasemide


subject: CHEBI:9637


subject: CHEBI:3219

subject_name: Bupropion

object_name: AIDS


subject: CHEBI:11909

subject_name: Sepranolone

object_name: alcohol abuse


subject: CHEBI:11909

object_name: alcohol dependence


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: myocardial infarction


subject: UNII:I031V2H011

object_name: Myocardial Infarction, CTCAE


subject: UNII:I031V2H011

object_name: Myocardial Infarction by ECG Finding


subject: UNII:I031V2H011

object_name: coronary artery disorder


subject: CHEBI:23359

subject_name: colchicine

object_name: idiopathic recurrent pericarditis


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:75998

subject_name: Trametinib

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:75998

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:75998

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:75998

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:75998

object_name: metastatic prostate carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:4026

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:4026

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:4027

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:4027

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:4027

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4027

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4027

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4027

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4027

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4027

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4027

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4027

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:4027

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4027

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:4027

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4027

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:4027

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C3640211

subject_name: Multi-epitope Folate Receptor Alpha Peptide Vaccine

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C3640211

object_name: Ovarian cancer stage IV


subject: UMLS:C3640211

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C3640211

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C3640211

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C3640211

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: UMLS:C3640211

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C3640211

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: malignant neoplasm of breast stage IIb


subject: UMLS:C3640211

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C3640211

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C3640211

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C3640211

object_name: Recurrent ovarian cancer


subject: UMLS:C3640211

object_name: Breast cancer recurrent


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: latent autoimmune diabetes in adults


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C4305824


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: castration-resistant prostate carcinoma


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Chemotherapy-Related Leukemia


subject: UMLS:C0003442

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C0003442

object_name: acute biphenotypic leukemia


subject: UMLS:C0003442

object_name: Infant Acute Biphenotypic Leukemia


subject: UMLS:C0003442


subject: UMLS:C0003442

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C0003442

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C0003442

object_name: Langerhans cell histiocytosis


subject: UMLS:C0003442

object_name: Langerhans cell histiocytosis specific to adulthood


subject: UMLS:C0003442

object_name: Neoplasm, Residual


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:681569

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:681569

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:681569

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Langerhans cell histiocytosis specific to childhood


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UMLS:C3892863

subject_name: filgrastim-sndz


subject: UMLS:C3892863

object_name: acute leukemia


subject: UMLS:C3892863

object_name: Hodgkin Disease


subject: UMLS:C3892863

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C3892863

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C3892863

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3892863

object_name: non-Hodgkin lymphoma


subject: UMLS:C3892863

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C3892863

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3892863

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3892863

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3892863

object_name: acute myeloid leukemia


subject: UMLS:C3892863

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C3892863

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C3892863

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C3892863

object_name: Acute lymphoid leukemia in remission


subject: UMLS:C3892863

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C3892863

object_name: acute biphenotypic leukemia


subject: UMLS:C3892863

object_name: Infant Acute Biphenotypic Leukemia


subject: UMLS:C3892863

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C3892863

object_name: chronic myelomonocytic leukemia


subject: UMLS:C3892863

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C3892863

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3892863

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C3892863


subject: UMLS:C3892863

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C3892863

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C3892863

object_name: Langerhans cell histiocytosis


subject: UMLS:C3892863

object_name: Langerhans cell histiocytosis specific to childhood


subject: UMLS:C3892863

object_name: Langerhans cell histiocytosis specific to adulthood


subject: UMLS:C3892863

object_name: Myelodysplasia


subject: UMLS:C3892863

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3892863

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3892863

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3892863

object_name: Neoplasm, Residual


subject: PUBCHEM.COMPOUND:3367

object_name: Chemotherapy-Related Leukemia


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:109549

subject_name: Ramelteon

object_name: hypertension


subject: CHEBI:109549

object_name: Hypertension, CTCAE


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E

object_name: Waldenstrom's macroglobulinemia, without mention of remission


subject: UNII:4Z63YK6E0E

object_name: Waldenstrom's hypergammaglobulinemia


subject: UNII:4Z63YK6E0E

object_name: Waldenstrom's disease


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:231681

subject_name: olaratumab

object_name: Solid Neoplasm


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: malignant epithelial tumor of ovary


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: antiphospholipid syndrome


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Immunoglobulin Light Chain Deposition


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:91397

object_name: amyloidosis


subject: CHEBI:91397


subject: UNII:G9WJT6RD29

subject_name: Burosumab

object_name: Oncogenic osteomalacia


subject: UMLS:C3896830


subject: UMLS:C3274915

subject_name: Globo H-KLH immunostimulant OPT-822

object_name: ovarian cancer


subject: UMLS:C3274915

object_name: ovarian neoplasm


subject: UMLS:C3274915

object_name: ovarian carcinoma


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Specific reading disorder


subject: CHEBI:127342

object_name: Reading disorder


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: Dyslipidemia


subject: CHEBI:135285

object_name: schizophrenia


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: human papilloma virus infection


subject: UNII:M89N0Q7EQR

object_name: vulvar neoplasm


subject: UNII:M89N0Q7EQR

object_name: cervical intraepithelial neoplasia


subject: UNII:M89N0Q7EQR

object_name: dysplasia of cervix


subject: UNII:M89N0Q7EQR

object_name: vulvar disease


subject: UNII:M89N0Q7EQR

object_name: in situ carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: vulva cancer


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Family history of ischemic heart disease


subject: CHEBI:63660

object_name: myocardial ischemia


subject: CHEBI:63660


subject: CHEBI:63660

object_name: acute coronary syndrome


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:8378

subject_name: Prednisolone

object_name: nephrotic syndrome


subject: CHEBI:8378

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:2549

subject_name: Albuterol


subject: CHEBI:2549

object_name: Bohring-Opitz syndrome


subject: CHEBI:2549

object_name: Buschke-Ollendorff syndrome


subject: UMLS:C4287766

object_name: ovarian cancer


subject: UMLS:C4287766

object_name: ovarian neoplasm


subject: UMLS:C4287766

object_name: ovarian carcinoma


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:233362

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:233362

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C5206815

object_name: Childhood Breast Carcinoma


subject: UMLS:C5206815

object_name: breast carcinoma


subject: UMLS:C5206815

object_name: breast cancer


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Hypoxia, CTCAE


subject: CHEBI:25805

object_name: Hypercapnia


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UNII:8BR2SOL3L1

object_name: Stage IVB Prostate Cancer AJCC v8


subject: DRUGBANK:DB12813

subject_name: Radium Ra-223


subject: UNII:X89XV46R07

subject_name: technetium Tc 99m medronate

object_name: castration-resistant prostate carcinoma


subject: UNII:X89XV46R07


subject: UNII:X89XV46R07

object_name: Metastatic malignant neoplasm to bone


subject: PUBCHEM.COMPOUND:131704315

subject_name: Technetium Tc-99m medronate


subject: PUBCHEM.COMPOUND:131704315


subject: PUBCHEM.COMPOUND:131704315


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: esophagitis


subject: CHEBI:6375

object_name: Esophagitis, CTCAE


subject: CHEBI:6375

object_name: Reflux


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: Compulsion


subject: CHEBI:146178

object_name: Somatic symptom disorder


subject: CHEBI:146178

object_name: body dysmorphic disorder


subject: CHEBI:146178

object_name: Illness anxiety disorder


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:68534

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:71200

object_name: amyotrophic lateral sclerosis


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Muscle Atrophy


subject: CHEBI:84094

object_name: osteoarthritis


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537

object_name: Physical trauma


subject: UMLS:C4721537

object_name: Injury


subject: UMLS:C4721537

object_name: Trauma


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:15365

subject_name: Aspirin

object_name: Moderate pain


subject: CHEBI:15365

object_name: Moderate Extremity Pain


subject: CHEBI:15365

object_name: Neck Pain Score 4


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Childhood Breast Carcinoma


subject: CHEBI:17061

object_name: breast carcinoma


subject: CHEBI:17061

object_name: breast cancer


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: Osteochondritis


subject: UMLS:C3714638

object_name: Compulsion


subject: UMLS:C3714638


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: DRUGBANK:DB17554

object_name: chronic myelomonocytic leukemia


subject: DRUGBANK:DB17554

object_name: Myelodysplasia


subject: DRUGBANK:DB17554

object_name: Miller-Dieker lissencephaly syndrome


subject: DRUGBANK:DB17554

object_name: myoclonic dystonia 11


subject: DRUGBANK:DB17554

object_name: acute myeloid leukemia


subject: UNII:47RRR83SK7

subject_name: [OBSOLETE] interferon alfa-2a

object_name: uveitis


subject: UNII:47RRR83SK7

object_name: Uveitis, CTCAE


subject: UNII:47RRR83SK7

object_name: Behcet disease


subject: CHEMBL.COMPOUND:CHEMBL2108508

subject_name: INTERFERON ALFA-2A


subject: CHEMBL.COMPOUND:CHEMBL2108508


subject: CHEMBL.COMPOUND:CHEMBL2108508


subject: UMLS:C0021734

subject_name: Roferon-A


subject: UMLS:C0021734


subject: UMLS:C0021734


subject: CHEBI:52717

subject_name: Bortezomib

object_name: nasopharyngeal carcinoma


subject: CHEBI:52717

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:56R994WX4L

subject_name: Ilginatinib

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:56R994WX4L


subject: UNII:56R994WX4L

object_name: myelofibrosis


subject: UMLS:C3273826


subject: UMLS:C3273826


subject: UMLS:C3273826


subject: UMLS:C4330908

object_name: Refractory Lymphoma


subject: UMLS:C4330908

object_name: Unresectable Solid Neoplasm


subject: UMLS:C4330908

object_name: Recurrent Lymphoma


subject: UMLS:C4330908

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4330908

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C4330908

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C4330908

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C4330908

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: UMLS:C4330908

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: UMLS:C4330908

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4330908

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4330908

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C4330908

object_name: triple-negative breast carcinoma


subject: UMLS:C4330908

object_name: Progesterone Receptor Negative


subject: UMLS:C4330908

object_name: Estrogen Receptor Negative


subject: UMLS:C4330908

object_name: HER2/Neu Negative


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: asthma


subject: CHEBI:80774

subject_name: taurursodiol


subject: UMLS:C1313227

object_name: bacteriemia


subject: UMLS:C1313227

object_name: Bacteremia, CTCAE


subject: UMLS:C1313227

object_name: Fungemia


subject: UMLS:C1313227

object_name: Fungemia, CTCAE


subject: UMLS:C1313227

object_name: Sepsis


subject: UMLS:C1313227

object_name: Sepsis, CTCAE


subject: UMLS:C4525955

subject_name: Anti-CTLA4 Monoclonal Antibody BMS-986218

object_name: Advanced cancer


subject: CHEBI:44915

subject_name: Propofol

object_name: Delayed Emergence from Anesthesia


subject: CHEBI:16302

object_name: CYP2D6 polymorphism


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Nasopharyngeal cancer recurrent


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:229643

subject_name: Zavegepant


subject: UMLS:C5417926


subject: CHEBI:63115

subject_name: Fingolimod

object_name: AUTONOMIC NERVOUS SYSTEM DYSFUNCTION


subject: CHEBI:134726

subject_name: Istradefylline

object_name: Restless legs


subject: CHEBI:134726

object_name: sleep disorder


subject: UMLS:C0673472


subject: UMLS:C0673472


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin

object_name: anovulation


subject: PUBCHEM.COMPOUND:21888462

object_name: Female infertility associated with anovulation


subject: UMLS:C0595531

subject_name: Menopur


subject: UMLS:C0595531


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Obstructive sleep apnea of adult


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:228346

object_name: endogenous depression


subject: CHEBI:228346

object_name: major depressive disorder


subject: UMLS:C5392742

object_name: rheumatoid arthritis


subject: CHEBI:16349

subject_name: Citrulline

object_name: Intestinal Failure


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: Crohn disease


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: wet macular degeneration


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: cancer pain


subject: CHEBI:9654

subject_name: Trazodone

object_name: Alzheimer disease


subject: UMLS:C5203412

subject_name: Midazolam Liquid Injection

object_name: Sedation complication


subject: UMLS:C5203412

object_name: gastric ulcer


subject: UMLS:C5203412

object_name: Gastric Ulcer, CTCAE


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130

object_name: Heartburn


subject: CHEBI:9130


subject: CHEBI:9130


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: dedifferentiated liposarcoma


subject: UNII:W0ZE0NT8IF

object_name: malignant soft tissue neoplasm


subject: UNII:W0ZE0NT8IF

object_name: sarcoma


subject: UNII:W0ZE0NT8IF


subject: UNII:W0ZE0NT8IF

object_name: Metastatic Dedifferentiated Liposarcoma


subject: UNII:W0ZE0NT8IF

object_name: Recurrent Dedifferentiated Liposarcoma


subject: UNII:W0ZE0NT8IF

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:W0ZE0NT8IF

object_name: Adult Soft Tissue Sarcoma


subject: UNII:W0ZE0NT8IF

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:W0ZE0NT8IF

object_name: soft tissue sarcoma


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: PUBCHEM.COMPOUND:6437075

subject_name: ticarcillin-clavulanic acid

object_name: Sepsis


subject: PUBCHEM.COMPOUND:6437075

object_name: Sepsis, CTCAE


subject: UMLS:C0145918


subject: UMLS:C0145918


subject: UMLS:C2936526

subject_name: Serotonin 5-HT3 Receptor Antagonists

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: cholesterol metabolism disease


subject: MESH:C109545

subject_name: RV3 rotavirus vaccine

object_name: Viral gastroenteritis due to Rotavirus


subject: CHEBI:141439

subject_name: Ile-Asp

object_name: poliomyelitis


subject: UniProtKB:P20067

subject_name: ID1_MOUSE DNA-binding protein inhibitor ID-1 (sprot)


subject: PR:000000039

subject_name: DNA-binding protein inhibitor ID-1


subject: CHEBI:74073

subject_name: Ile-Met


subject: CHEBI:30366

subject_name: imidazolide


subject: GTOPDB:8002

subject_name: bavituximab

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C5666890

subject_name: BTK Degrader BGB-16673

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C5666890

object_name: Richter syndrome


subject: UMLS:C5666890

object_name: Diffuse large B-cell lymphoma, unclassifiable, NOS


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: DRUGBANK:DB17476

object_name: Advanced Malignant Solid Neoplasm


subject: DRUGBANK:DB17476

object_name: esophageal squamous cell carcinoma


subject: DRUGBANK:DB17476

object_name: colorectal cancer


subject: DRUGBANK:DB17476

object_name: colorectal carcinoma


subject: DRUGBANK:DB17476

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB17476

object_name: bladder tumor


subject: DRUGBANK:DB17476

object_name: urinary bladder carcinoma


subject: DRUGBANK:DB17476

object_name: urinary bladder cancer


subject: DRUGBANK:DB17476

object_name: childhood bladder carcinoma


subject: DRUGBANK:DB17476

object_name: Stomach cancer


subject: DRUGBANK:DB17476

object_name: gastric cancer


subject: DRUGBANK:DB17476

object_name: lung cancer


subject: DRUGBANK:DB17476

object_name: lung neoplasm


subject: DRUGBANK:DB17476

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: Shock


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: Drug Interactions


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: anemia


subject: CHEBI:85078

object_name: Anemia, CTCAE


subject: CHEBI:34574


subject: CHEBI:34574


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:42085


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:16026


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: CHEBI:2247


subject: PR:000010511

subject_name: molybdenum cofactor sulfurase

object_name: benign prostatic hyperplasia


subject: PR:000015276

subject_name: sperm mitochondrial-associated cysteine-rich protein


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Crohn disease


subject: UNII:1C6V77QF41

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: sarcopenia


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Sicca Syndrome


subject: UMLS:C5239121

subject_name: Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641

object_name: head and neck squamous cell carcinoma


subject: UNII:L93WSG9AAU


subject: UNII:K679OBS311

subject_name: Carboxymethylcellulose Sodium

object_name: atopic conjunctivitis


subject: CHEBI:135552

subject_name: Prucalopride

object_name: opioid-induced constipation


subject: PUBCHEM.COMPOUND:16131070

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL4594475

subject_name: GLUCAGON-LIKE PEPTIDE 1


subject: UNII:OCC6TB3P6K

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:OCC6TB3P6K

object_name: obesity


subject: UNII:OCC6TB3P6K

object_name: Obesity, CTCAE


subject: UMLS:C4279890

object_name: Childhood Breast Carcinoma


subject: UMLS:C4279890

object_name: breast carcinoma


subject: UMLS:C4279890

object_name: breast cancer


subject: UMLS:C1704298

subject_name: Recombinant Luteinizing Hormone

object_name: female infertility


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: myelofibrosis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: anal squamous cell carcinoma


subject: CHEBI:4026

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: skin squamous cell carcinoma


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:4985

object_name: anal margin carcinoma


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5203527

subject_name: Methotrexate Liquid Injection

object_name: Nail psoriasis


subject: UMLS:C5447482

subject_name: Ligufalimab

object_name: adult acute myeloid leukemia


subject: UMLS:C5447482

object_name: Leukemia - acute myeloid leukemia (AML)


subject: UMLS:C5447482

object_name: childhood acute myeloid leukemia


subject: UMLS:C5447482

object_name: acute myeloid leukemia


subject: UMLS:C5777836

subject_name: ESKETAMINE HYDROCHLORIDE 28 mg in 0.2 mL NASAL SOLUTION [Spravato]

object_name: Injuries, Surgical


subject: UMLS:C4287775

object_name: Hepatic impairment


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: post partum contraception


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: metastatic colorectal cancer


subject: UMLS:C2828372


subject: UMLS:C5447471

subject_name: CXCR2 Agonist MGTA-145

object_name: sickle cell disease


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: periodontitis, chronic, adult


subject: UMLS:C0016004

object_name: chronic periodontitis


subject: UMLS:C0009343

subject_name: Collagen Fleece


subject: UMLS:C0009343


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR

object_name: smoldering plasma cell myeloma


subject: PUBCHEM.COMPOUND:44573417

object_name: monoclonal gammopathy of uncertain significance


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: ovarian cancer


subject: UNII:5ZHA5P4PFX

object_name: ovarian neoplasm


subject: UNII:5ZHA5P4PFX

object_name: ovarian carcinoma


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: atopic eczema


subject: CHEBI:95067

subject_name: Iniparib

object_name: Solid Neoplasm


subject: UMLS:C4721566


subject: UMLS:C1831868

subject_name: BSI 201


subject: UMLS:C0147919

subject_name: uro-vaxom

object_name: Recurrent urinary tract infections


subject: UMLS:C0147919

object_name: spinal cord injury


subject: UMLS:C4086017

subject_name: BTK Inhibitor

object_name: mantle cell lymphoma


subject: UMLS:C4086017

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4086017

object_name: Burkitt lymphoma


subject: UMLS:C4086017

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C4086017

object_name: Adult Burkitt Lymphoma


subject: UMLS:C4086017

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Encephalopathy Related to COVID-19


subject: PUBCHEM.COMPOUND:92043599

object_name: brain disorder


subject: PUBCHEM.COMPOUND:92043599

object_name: Encephalopathy, CTCAE 5.0


subject: PUBCHEM.COMPOUND:92043599

object_name: Encephalopathy, CTCAE 3.0


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: UMLS:C3896574

subject_name: Iodine I 124 Monoclonal Antibody 3F8

object_name: Childhood Neuroblastoma


subject: UMLS:C3896574

object_name: neuroblastoma


subject: UMLS:C3896574

object_name: melanoma


subject: UMLS:C3896574

object_name: malignant soft tissue neoplasm


subject: UMLS:C3896574

object_name: sarcoma


subject: CHEBI:8802

subject_name: Remifentanil

object_name: postherpetic neuralgia


subject: CHEBI:6933

subject_name: Midodrine

object_name: Postoperative Vasoplegic Syndrome


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Stage IV Nasopharyngeal Carcinoma


subject: UNII:5S371K6132

object_name: Nasopharyngeal cancer recurrent


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: PUBCHEM.COMPOUND:2352

subject_name: beraprost

object_name: type 2 diabetes mellitus


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: diabetic kidney disease


subject: UNII:2AD53WQ2CX

object_name: chronic idiopathic urticaria


subject: CHEBI:151315

subject_name: Heparin

object_name: infertility


subject: KEGG.COMPOUND:C00374


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Multiple Metastases


subject: CHEBI:70839

object_name: mycosis fungoides


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:90881

subject_name: Camptosar

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:90881

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:90881

object_name: Burkitt lymphoma


subject: CHEBI:90881

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:90881

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:90881

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:90881

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:90881

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:90881

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:90881

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:90881

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:90881

object_name: Recurrent Childhood Liver Cancer


subject: CHEBI:90881

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:90881

object_name: Melanoma recurrent


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent tumors of the Ewing's family


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Visual Pathway Glioma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Medulloblastoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Childhood Ependymoma


subject: PUBCHEM.COMPOUND:43805

object_name: Neuroblastoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Osteosarcoma recurrent


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: UMLS:C1314429

object_name: Burkitt lymphoma


subject: UMLS:C1314429

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C1314429

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Large Cell Lymphoma


subject: UMLS:C1314429

object_name: Recurrent Kidney Wilms Tumor


subject: UMLS:C1314429

object_name: Childhood Immunoblastic Lymphoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: UMLS:C1314429

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: UMLS:C1314429

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C1314429

object_name: Recurrent tumors of the Ewing's family


subject: UMLS:C1314429

object_name: Recurrent Childhood Liver Cancer


subject: UMLS:C1314429

object_name: Nasopharyngeal cancer recurrent


subject: UMLS:C1314429

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: UMLS:C1314429

object_name: Recurrent Childhood Visual Pathway Glioma


subject: UMLS:C1314429

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C1314429

object_name: Recurrent Childhood Ependymoma


subject: UMLS:C1314429

object_name: Neuroblastoma recurrent


subject: UMLS:C1314429

object_name: Osteosarcoma recurrent


subject: UMLS:C1314429

object_name: Melanoma recurrent


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Mycobacterium avium complex disease


subject: CHEBI:75179

object_name: HIV infection


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: juvenile myelomonocytic leukemia


subject: UNII:37CQ2C7X93

object_name: chronic myelomonocytic leukemia


subject: UNII:37CQ2C7X93

object_name: Adult Myelodysplastic Syndrome


subject: UNII:37CQ2C7X93

object_name: childhood myelodysplastic syndrome


subject: UNII:37CQ2C7X93

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:37CQ2C7X93

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: UNII:37CQ2C7X93

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:37CQ2C7X93

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:37CQ2C7X93

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:37CQ2C7X93

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: MESH:C557525

subject_name: SB939 compound

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:56603532

subject_name: Pracinostat


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: periodontitis


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Androgen excess


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Miosis


subject: CHEBI:6129

object_name: Constricted pupil (finding)


subject: CHEBI:75922

subject_name: Nepafenac


subject: CHEBI:75922


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: peanut allergy


subject: UMLS:C0378942


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Hormone receptor positive tumor


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C1711297

subject_name: MUC-1 Peptide Vaccine

object_name: ductal breast carcinoma in situ


subject: UMLS:C3884609

object_name: acute coronary syndrome


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: diverticulitis


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: pregnancy disorder


subject: UNII:UMD07X179E

object_name: Antiphospholipid syndrome in pregnancy


subject: UNII:UMD07X179E

object_name: Lupus anticoagulant disorder


subject: UNII:UMD07X179E

object_name: high-risk pregnancy


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: UMLS:C1172157


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: tracheal stenosis


subject: CHEBI:194095

object_name: Tracheal Stenosis, CTCAE


subject: CHEBI:194095

object_name: laryngostenosis


subject: CHEBI:194095

object_name: Laryngeal Stenosis, CTCAE


subject: CHEBI:194095

object_name: Subglottic stenosis


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: calcium measurement


subject: CHEBI:3311

object_name: Endogenous obesity


subject: CHEBI:52010

subject_name: chlorphenamine


subject: CHEBI:52010

object_name: COVID-19 respiratory infection


subject: CHEBI:52010

object_name: SARS-CoV-2 acute respiratory disease


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Vaccine exposure via breast milk


subject: MESH:D000086663

object_name: Breastfeeding (mother)


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Chemotherapy induced neutropenia


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: GTOPDB:11326

subject_name: atibuclimab

object_name: acute respiratory distress syndrome


subject: GTOPDB:11326

object_name: adult acute respiratory distress syndrome


subject: GTOPDB:11326

object_name: Adult Respiratory Distress Syndrome, CTCAE


subject: GTOPDB:11326

object_name: Acute lung injury/Acute respiratory distress syndrome (ARDS)


subject: GTOPDB:11326

object_name: acute lung injury


subject: UNII:23IQ3PO968

subject_name: ATIBUCLIMAB


subject: UNII:23IQ3PO968


subject: UNII:23IQ3PO968


subject: UNII:23IQ3PO968


subject: UNII:23IQ3PO968


subject: UMLS:C5417932

subject_name: IC 14


subject: UMLS:C5417932


subject: UMLS:C5417932


subject: UMLS:C5417932


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Adult Gliosarcoma


subject: CHEBI:9168

object_name: gliosarcoma


subject: CHEBI:9168

object_name: Childhood Gliosarcoma


subject: UNII:T60AV22R32

subject_name: Chlorazine

object_name: epilepsy


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:5613

subject_name: Haloperidol


subject: CHEBI:60654

subject_name: valproate

object_name: delirium


subject: CHEBI:60654

object_name: Delirium, CTCAE


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:72313

subject_name: pasireotide aspartate

object_name: acromegaly


subject: CHEBI:72313

object_name: Acral overgrowth


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Methadone dependence


subject: UMLS:C0003289

subject_name: Antidepressive Agents

object_name: acute coronary syndrome


subject: UMLS:C0003289

object_name: Depressive Symptoms


subject: GTOPDB:437

object_name: Chemotherapy-Induced Thrombocytopenia


subject: UMLS:C0950716


subject: UMLS:C0974143

subject_name: Aloe vera gel

object_name: periapical tissue disease


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: urothelial carcinoma


subject: UNII:W0ZE0NT8IF

object_name: transitional cell carcinoma


subject: UNII:W0ZE0NT8IF

object_name: Disseminated Malignant Neoplasm


subject: UNII:W0ZE0NT8IF

object_name: Embolism, Tumor


subject: UNII:W0ZE0NT8IF

object_name: Neoplasm Metastasis


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5785765

object_name: ovarian cancer


subject: UMLS:C5785765

object_name: ovarian neoplasm


subject: UMLS:C5785765

object_name: ovarian carcinoma


subject: UNII:Q40Q9N063P

subject_name: ACETIC ACID

object_name: Traditional Serrated Adenoma


subject: UNII:Q40Q9N063P

object_name: COLON NOS POLYPECTOMY TUBULAR ADENOMA


subject: UNII:Q40Q9N063P

object_name: colorectal cancer


subject: UNII:Q40Q9N063P

object_name: colorectal carcinoma


subject: UNII:Q40Q9N063P

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:40410

subject_name: N-acetylglycine


subject: CHEBI:40410


subject: CHEBI:40410


subject: CHEBI:40410


subject: CHEBI:40410


subject: UMLS:C1550049

subject_name: Acetic Acid - Specimen Additive


subject: UMLS:C1550049


subject: UMLS:C1550049


subject: UMLS:C1550049


subject: UMLS:C1550049


subject: UMLS:C0000985

subject_name: Acetic Acids


subject: UMLS:C0000985


subject: UMLS:C0000985


subject: UMLS:C0000985


subject: UMLS:C0000985


subject: CHEBI:15366

subject_name: Acetic acid


subject: CHEBI:15366


subject: CHEBI:15366


subject: CHEBI:15366


subject: CHEBI:15366


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: colon cancer


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:15365

subject_name: Aspirin

object_name: Well adult


subject: CHEBI:74947

subject_name: Thalidomide

object_name: castration-resistant prostate carcinoma


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: 3-lead electrocardiogram rhythm strip: heart rate


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: UNII:C8ADC441ME

subject_name: Ivabradine


subject: CHEBI:84363

object_name: cardiovascular disorder


subject: CHEBI:84363

object_name: Pediatric Obesity


subject: CHEBI:84363

object_name: Insulin resistance


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: CHEBI:2376


subject: CHEBI:167309

subject_name: Methadone

object_name: cocaine abuse


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Disorder related to lung transplantation


subject: UNII:G9WJT6RD29

subject_name: Burosumab

object_name: Rare Diseases


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Tinnitus


subject: CHEBI:26710

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:26710

object_name: Tinnitus, CTCAE 3.0


subject: GTOPDB:13045

subject_name: rocatinlimab

object_name: asthma


subject: CHEMBL.COMPOUND:CHEMBL4594567

subject_name: ROCATINLIMAB


subject: UMLS:C5669663

subject_name: Rocatinlimab


subject: CHEBI:8024

subject_name: Perindopril

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:8024

object_name: obesity


subject: CHEBI:8024

object_name: Obesity, CTCAE


subject: CHEBI:9468

subject_name: Tetracaine

object_name: Shoulder pain


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:22976653

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:22976653

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: PR:000012825


subject: CHEBI:50693

subject_name: Milrinone

object_name: Persistent pulmonary hypertension


subject: CHEBI:192614

subject_name: Homosildenafil


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:KE3U2023NP

subject_name: Poractant alfa

object_name: Chronic pulmonary insufficiency of prematurity


subject: UNII:KE3U2023NP

object_name: bronchopulmonary dysplasia


subject: UNII:KE3U2023NP

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:33569

subject_name: noradrenaline

object_name: congenital heart disease


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: coronary microvascular disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: peripheral vascular disease


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: peripheral arterial disease


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Insulin resistance


subject: UNII:71M78END5S


subject: UNII:71M78END5S


subject: UNII:71M78END5S


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: UMLS:C5854558

subject_name: Anti-PD-L1/Anti-CD47 Bispecific Monoclonal Antibody LB101

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5204486

subject_name: Imsapepimut

object_name: laryngeal squamous cell carcinoma


subject: UMLS:C5204486

object_name: oropharynx squamous cell carcinoma


subject: UMLS:C5204486

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C5204486

object_name: hypopharynx squamous cell carcinoma


subject: CHEBI:47426

subject_name: Furosemide

object_name: Soft Tissue Injuries


subject: UMLS:C2826158

subject_name: Selectikine

object_name: melanoma


subject: UMLS:C3831520

subject_name: Anti-CD3 Monoclonal Antibody

object_name: hepatitis C


subject: UMLS:C3831520

object_name: chronic hepatitis C virus infection


subject: UMLS:C1327799

subject_name: Autologous Dendritic Cell-Adenovirus P53 Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C1327799

object_name: breast carcinoma


subject: UMLS:C1327799

object_name: breast cancer


subject: MESH:C511203

subject_name: COLD-fX

object_name: respiratory tract infectious disorder


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Common Migraine


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:33704

subject_name: Amino acid

object_name: Dental Plaque


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C2917660

subject_name: Amino Acid [EPC]


subject: UNII:G6UF363ECX

object_name: nonpapillary renal cell carcinoma


subject: UNII:G6UF363ECX

object_name: clear cell renal carcinoma


subject: UNII:G6UF363ECX

object_name: renal cell adenocarcinoma


subject: UNII:G6UF363ECX

object_name: renal cell carcinoma


subject: UNII:G6UF363ECX

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: UNII:G6UF363ECX

object_name: renal carcinoma


subject: UNII:G6UF363ECX

object_name: kidney neoplasm


subject: UNII:G6UF363ECX

object_name: kidney cancer


subject: UMLS:C4308025

subject_name: AAA 617


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C3529183

object_name: primary biliary cholangitis


subject: CHEBI:50634

object_name: high altitude hypoxia


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic urothelial carcinoma


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:15367

subject_name: Tretinoin

object_name: adrenal cortex carcinoma


subject: CHEBI:15367

object_name: adenoid cystic carcinoma


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: melanoma


subject: UMLS:C4331912


subject: UMLS:C5432347

subject_name: Adynovi

object_name: hemophilia A


subject: UMLS:C1541461

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1541461

object_name: leukemia


subject: UMLS:C1541461

object_name: childhood leukemia


subject: UMLS:C1541461

object_name: adult lymphoma


subject: UMLS:C1541461

object_name: lymphoma


subject: UMLS:C1541461

object_name: pediatric lymphoma


subject: UNII:Q8L6AN59YY

subject_name: Bitopertin

object_name: erythropoietic protoporphyria


subject: CHEBI:124959

subject_name: Tilarginine

object_name: sarcopenia


subject: UMLS:C0069477


subject: CHEBI:29321

subject_name: sodium nitroprusside


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: PUBCHEM.COMPOUND:22976653

object_name: Intraventricular hemorrhage


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Interstitial lung disease due to systemic disease


subject: CHEBI:71200

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:71200

object_name: reactive angioendotheliomatosis


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: prostate carcinoma


subject: CHEBI:85078

object_name: prostate cancer


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: neuroendocrine carcinoma


subject: CHEBI:50634

object_name: stroke disorder


subject: CHEBI:50634

object_name: cerebrovascular disorder


subject: CHEBI:50634

object_name: Stroke (heart beat)


subject: CHEBI:50634

object_name: Stroke, CTCAE


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:85994

object_name: Vulval cancer metastatic


subject: CHEBI:85994

object_name: Recurrent Vulvar Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:39112

subject_name: Bosutinib

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:32599

object_name: Myofascial Trigger Point Pain


subject: CHEBI:91775

subject_name: RITODRINE

object_name: Premature birth


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage II Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage I Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage 0a Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IV Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage 0is Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage II Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage II Renal Pelvis Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage I Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage 0a Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage 0is Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IV Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage I Renal Pelvis Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage 0a Renal Pelvis Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage 0is Renal Pelvis Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: temporomandibular joint disorder


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: temporomandibular joint dysfunction syndrome


subject: CHEBI:15365

subject_name: Aspirin

object_name: familial avascular necrosis of femoral head


subject: CHEBI:15365

object_name: avascular necrosis of femoral head, primary, 1


subject: CHEBI:15365

object_name: Idiopathic aseptic necrosis of bone


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: skin disorder


subject: UMLS:C5203413

subject_name: Metoclopramide Liquid Injection

object_name: gastroparesis


subject: UMLS:C5203413

object_name: Delayed gastric emptying


subject: CHEBI:7514

subject_name: Neostigmine


subject: CHEBI:7514


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:6456

subject_name: Lidocaine

object_name: pediatric presentation of urinary tract infection


subject: UMLS:C1721378

subject_name: Galvus

object_name: Increased reactive oxygen species production


subject: UMLS:C1721378

object_name: diabetes mellitus


subject: CHEBI:135285

subject_name: Vildagliptin


subject: UNII:F333OQQ9UV

object_name: glioblastoma


subject: UNII:F333OQQ9UV

object_name: Brain Stem Glioblastoma


subject: UNII:F333OQQ9UV

object_name: glioma susceptibility 1


subject: UMLS:C2983762


subject: UMLS:C2983762